- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-IL-10
IL-10 Monoclonal Antibody for WB, IF/ICC, ELISA
Hôte / Isotype
Mouse / IgG2b
Réactivité testée
Humain et plus (3)
Applications
WB, IHC, IF/ICC, ELISA, Cell treatment
Conjugaison
Non conjugué
CloneNo.
8E4B6
N° de cat : 60269-1-Ig
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | ag14870 | 
| Résultats positifs en IF/ICC | cellules MOLT-4, | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:2000-1:8000 | 
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 1 publications below | 
| WB | See 76 publications below | 
| IHC | See 41 publications below | 
| IF | See 25 publications below | 
| ELISA | See 2 publications below | 
Informations sur le produit
60269-1-Ig cible IL-10 dans les applications de WB, IHC, IF/ICC, ELISA, Cell treatment et montre une réactivité avec des échantillons Humain
| Réactivité | Humain | 
| Réactivité citée | rat, Humain, Lapin, poisson-zèbre | 
| Hôte / Isotype | Mouse / IgG2b | 
| Clonalité | Monoclonal | 
| Type | Anticorps | 
| Immunogène | IL-10 Protéine recombinante Ag14870 | 
| Nom complet | interleukin 10 | 
| Masse moléculaire calculée | 21 kDa | 
| Poids moléculaire observé | 22 kDa | 
| Numéro d’acquisition GenBank | BC104252 | 
| Symbole du gène | IL-10 | 
| Identification du gène (NCBI) | 3586 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Purification par protéine A | 
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol | 
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. | 
Informations générales
Interleukin (IL)-10 is an anti-inflammatory cytokine, produced by T helper (Th) cells, macrophages, monocytes, and B cells, that plays a crucial role in preventing inflammatory and autoimmune pathologies. It downregulates the expression of Th1 cytokines, MHC class II antigens, and co-stimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. IL-10 can block NF-κB activity, and is involved in the regulation of the JAK-STAT signaling pathway. IL-10, along with its receptors, describes an important role in pathogenesis of various diseases, including infectious, inflammatory, autoimmune diseases. IL-10 mutations are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for IL-10 antibody 60269-1-Ig | Download protocol | 
| IHC protocol for IL-10 antibody 60269-1-Ig | Download protocol | 
| IF protocol for IL-10 antibody 60269-1-Ig | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
| Bioact Mater A bioactive composite hydrogel dressing that promotes healing of both acute and chronic diabetic skin wounds | ||
| Adv Healthc Mater One-Step Synthesis of Multifunctional Chitosan Hydrogel for Full-Thickness Wound Closure and Healing. | ||
| J Control Release 3D mesenchymal stem cell exosome-functionalized hydrogels for corneal wound healing | ||
| J Immunother Cancer Helicobacter pylori infection disturbs the tumor immune microenvironment and is associated with a discrepant prognosis in gastric de novo diffuse large B-cell lymphoma. | ||
| Mol Ther Host liver-derived extracellular vesicles deliver miR-142a-3p induces neutrophil extracellular traps via targeting WASL to block the development of Schistosoma japonicum. | 


